Arkolith/Insider Trading/MIRM/Form 4

Bjerkholt Eric

CHIEF FINANCIAL OFFICERMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Mar 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$670K
Net Open-Market Flow
-$670K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)7K$91.98$670K50K
Mar 15, 2026Option exercise(M)13K——57K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2026Option exercise(M)13K—$07K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001197350-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML